Information on admissions, scholarships, new courses, research studies and other events at schools and colleges ...
Ona Therapeutics Appoints Oncology Drug Development Veteran Dr. Antoine Yver as Chair to Accelerate ADC Programs to Clinical Inflection Points Brings over 35 years of oncology drug development ...
ProQR to Participate in Upcoming Investor Conferences in October 2025LEIDEN, Netherlands & CAMBRIDGE, Mass., Oct. 13, 2025 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq: PRQR) (ProQR), a company ...
Objective To inform the development of an evidence synthesis taxonomy, we aimed to identify and examine all classification ...
If approved, Scemblix will be indicated for adults with chronic myeloid leukemia (CML), both newly diagnosed and previously treated, expanding access to four times as many patients in Europe Scemblix ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback